Key Highlights
- Sachin Jain, M.D., MBA, joins with extensive experience in healthcare management and innovation.
- Julie Klapstein brings over 30 years of healthcare IT industry experience.
- Adam Stavisky offers insights from his tenure as SVP of U.S. Benefits for Walmart.
- Focus on chronic care, GLP-1 market, and emerging AI technologies.
- Commitment to improving between-visit care.
Source: Business Wire
Notable Quotes
- “Sachin Jain, Julie Klapstein, and Adam Stavisky have been at the forefront of healthcare innovation for decades and share a vision of transforming today’s models of care to serve tomorrow’s needs.” — Sean Duffy, CEO & Co-Founder at Omada Health
- “The rapid pace of innovation and the evolving GLP-1 market have the potential to transform chronic care management for weight health and diabetes.” — Sachin Jain, CEO at SCAN Group and SCAN Health Plan
SoHC's Take
Omada Health’s strategic addition of Sachin Jain, Julie Klapstein, and Adam Stavisky to its Board of Directors marks a significant step forward in its mission to transform chronic care. Each of these leaders brings a wealth of experience and unique perspectives that are crucial in navigating the dynamic healthcare landscape, especially with the advancements in GLP-1s and AI technologies. This move not only strengthens Omada’s leadership team but also enhances its capability to deliver innovative, between-visit care solutions. As the healthcare industry continues to evolve, Omada Health is poised to make substantial strides in improving patient outcomes and reducing healthcare costs, solidifying its position as a leader in virtual-first healthcare.
